Revenue from operation slumped 52.5% to Rs 49.28 crore in Q4 FY23 from Rs 103.71 crore recorded in the same period a year ago.

Pre-tax loss stood at Rs 9.84 crore in the fourth quarter of FY23 as compared to profit before tax of Rs 35.96 crore reported in Q4 FY22.

The company reported a negative EBITDA of Rs 16.17 crore in Q4 FY23 as against a positive EBITDA of Rs 34.88 crore in Q4 FY22. The firm posted negative EBITDA margin at 32.81% during the quarter.

The company's retail segment revenue was at Rs 26.2 crore (down 69% YoY) while enterprise segment revenue stood at Rs 31.3 crore (up 9% YoY), during the period under review.

On a full year basis, the company consolidated net profit slumped 92.3% to Rs 6.40 crore in FY23 as against Rs 83.19 crore recorded in FY22. Revenue stood at Rs 278.09 crore in FY23, down 18.7% year on year.

With respect to future outlook, Quick Heal Technologies said that it is planning to expand its footprint globally by extending retail and enterprise services to international clients. The firm is investing heavily into enterprise solutions, which offers a significantly larger market opportunity and is expected to grow 3 times faster than the retail market.

Meanwhile, the company's board has recommended a final dividend of Rs 2.5 per equity share for the financial year 2022-23.

Separately, the board of directors of the company has announced the resignation of its chief financial officer (CFO), Navin Sharma, effective from the closure of business hours on 18 April 2023. Sharma resigned from the post due to personal reasons.

Further, the company's board announced the appointment of Ankit Maheshwari as the new CFO of the company, effective from 26 April 2023.

Quick Heal Technologies is engaged in the business of providing security software products. The company caters to both domestic and international market.

Powered by Capital Market - Live News

Quick Heal Technologies announced that the Board of Directors of the Company at its meeting held on 17 April 2023, has recommended a Final dividend of Rs.2.50 per share (i.e.25%), subject to the approval of the shareholders.

Powered by Capital Market - Live News

Net loss of Quick Heal Technologies reported to Rs 6.64 crore in the quarter ended March 2023 as against net profit of Rs 28.09 crore during the previous quarter ended March 2022. Sales declined 52.48% to Rs 49.28 crore in the quarter ended March 2023 as against Rs 103.71 crore during the previous quarter ended March 2022.

For the full year,net profit declined 92.31% to Rs 6.40 crore in the year ended March 2023 as against Rs 83.19 crore during the previous year ended March 2022. Sales declined 18.66% to Rs 278.09 crore in the year ended March 2023 as against Rs 341.90 crore during the previous year ended March 2022.

Powered by Capital Market - Live News

Quick Heal Technologies will hold a meeting of the Board of Directors of the Company on 17 April 2023.

Powered by Capital Market - Live News